Penumbra Receivables 2014-2026 | PEN
Penumbra receivables from 2014 to 2026. Receivables can be defined as the total amount of collectibles for a company
- Penumbra receivables for the quarter ending March 31, 2026 were $0.183B, a 9.12% increase year-over-year.
- Penumbra receivables for 2025 were $0.19B, a 13.33% increase from 2024.
- Penumbra receivables for 2024 were $0.168B, a 16.9% decline from 2023.
- Penumbra receivables for 2023 were $0.202B, a 0.79% decline from 2022.
|
Penumbra Annual Receivables (Millions of US $) |
|
|---|---|
| 2025 | $190 |
| 2024 | $168 |
| 2023 | $202 |
| 2022 | $203 |
| 2021 | $134 |
| 2020 | $115 |
| 2019 | $106 |
| 2018 | $82 |
| 2017 | $58 |
| 2016 | $43 |
| 2015 | $29 |
| 2014 | $19 |
| 2013 | $13 |
|
Penumbra Quarterly Receivables (Millions of US $) |
|
|---|---|
| 2026-03-31 | $183 |
| 2025-12-31 | $190 |
| 2025-09-30 | $183 |
| 2025-06-30 | $176 |
| 2025-03-31 | $168 |
| 2024-12-31 | $168 |
| 2024-09-30 | $176 |
| 2024-06-30 | $201 |
| 2024-03-31 | $192 |
| 2023-12-31 | $202 |
| 2023-09-30 | $207 |
| 2023-06-30 | $209 |
| 2023-03-31 | $207 |
| 2022-12-31 | $203 |
| 2022-09-30 | $189 |
| 2022-06-30 | $187 |
| 2022-03-31 | $143 |
| 2021-12-31 | $134 |
| 2021-09-30 | $120 |
| 2021-06-30 | $137 |
| 2021-03-31 | $126 |
| 2020-12-31 | $115 |
| 2020-09-30 | $113 |
| 2020-06-30 | $98 |
| 2020-03-31 | $104 |
| 2019-12-31 | $106 |
| 2019-09-30 | $102 |
| 2019-06-30 | $99 |
| 2019-03-31 | $95 |
| 2018-12-31 | $82 |
| 2018-09-30 | $80 |
| 2018-06-30 | $74 |
| 2018-03-31 | $65 |
| 2017-12-31 | $58 |
| 2017-09-30 | $48 |
| 2017-06-30 | $49 |
| 2017-03-31 | $45 |
| 2016-12-31 | $43 |
| 2016-09-30 | $37 |
| 2016-06-30 | $35 |
| 2016-03-31 | $31 |
| 2015-12-31 | $29 |
| 2015-09-30 | $26 |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2013-12-31 | $13 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $12.437B | $1.404B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $172.436B | 20.03 |
| Intuitive Surgical (ISRG) | United States | $142.710B | 51.59 |
| Edwards Lifesciences (EW) | United States | $49.450B | 31.81 |
| IDEXX Laboratories (IDXX) | United States | $43.049B | 40.19 |
| Waters (WAT) | United States | $35.175B | 26.38 |
| Alcon (ALC) | Switzerland | $32.239B | 20.50 |
| IQVIA Holdings (IQV) | United States | $28.007B | 15.06 |
| DexCom (DXCM) | United States | $26.652B | 29.64 |
| Mettler-Toledo (MTD) | United States | $23.523B | 26.75 |
| STERIS (STE) | Ireland | $19.531B | 19.70 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.276B | 0.00 |
| Coloplast (CLPBY) | Denmark | $12.868B | 17.30 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.635B | 9.28 |
| Globus Medical (GMED) | United States | $10.750B | 17.84 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $7.705B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Teleflex (TFX) | United States | $5.386B | 11.35 |
| Sysmex ADR (SSMXY) | Japan | $5.369B | 22.45 |
| LivaNova (LIVN) | United Kingdom | $4.324B | 22.49 |
| Veracyte (VCYT) | United States | $4.244B | 36.43 |
| Integer Holdings (ITGR) | United States | $3.059B | 14.30 |
| TransMedics (TMDX) | United States | $2.610B | 30.82 |
| AxoGen (AXGN) | United States | $2.390B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.821B | 19.76 |
| UFP Technologies (UFPT) | United States | $1.805B | 23.78 |
| Pulse Biosciences (PLSE) | United States | $1.779B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.460B | 12.38 |
| Integra LifeSciences Holdings (IART) | United States | $1.369B | 7.46 |
| Alphatec Holdings (ATEC) | United States | $1.315B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.199B | 0.00 |
| IRadimed (IRMD) | United States | $1.172B | 50.10 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.167B | 27.67 |
| OPKO Health (OPK) | United States | $1.080B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.983B | 0.00 |
| Artivion (AORT) | United States | $0.977B | 30.97 |
| Anteris Technologies Global (AVR) | Australia | $0.934B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.906B | 0.00 |
| SiBone (SIBN) | United States | $0.702B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.610B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 29.80 |
| NeuroPace (NPCE) | United States | $0.524B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.515B | 13.65 |
| AngioDynamics (ANGO) | United States | $0.512B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.512B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.466B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.410B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.397B | 1151.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.362B | 0.00 |
| 908 Devices (MASS) | United States | $0.327B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.285B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.283B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.260B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.209B | 0.00 |
| RxSight (RXST) | United States | $0.205B | 0.00 |
| FocalTherics (FOCL) | France | $0.184B | 0.00 |
| Inogen (INGN) | United States | $0.174B | 0.00 |
| Hyperfine (HYPR) | United States | $0.148B | 0.00 |
| CVRx (CVRX) | United States | $0.129B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.124B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.113B | 0.00 |
| Neuronetics (STIM) | United States | $0.084B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.073B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Precision Optics (POCI) | United States | $0.059B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Envoy Medical (COCH) | United States | $0.051B | 0.00 |
| DarioHealth (DRIO) | United States | $0.046B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.046B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.045B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.043B | 0.00 | |
| Accuray (ARAY) | United States | $0.037B | 0.00 |
| InspireMD (NSPR) | United States | $0.034B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.007B | 0.00 |
| NexGel (NXGL) | United States | $0.006B | 0.00 |
| PAVmed (PAVM) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |